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Abstract
Ubiquitin synergistically augmented the production of tumor necrosis factor alpha (TNF-K) in the presence of
lipopolysaccharide (LPS) in murine macrophage cell line RAW 264.7. To investigate the mechanism of this augmentation, we
analyzed the effect of ubiquitin during TNF-K mRNA synthesis and degradation, and TNF-K degradation on RAW 264.7
cells stimulated by LPS. It is found that ubiquitin augmented TNF-K mRNA synthesis. Ubiquitin did not affect the
degradation of TNF-K mRNA and TNF-K. In the presence of LPS, extracellular accumulation of TNF-K by ubiquitin was
twice than those by LPS, but intracellular accumulation of TNF-K produced by ubiquitin with LPS or by LPS had no
difference. These data indicate that ubiquitin might induce TNF-K accumulation mainly by up-regulation of the TNF-K gene
transcription. Although extracellular functions of ubiquitin remain largely unknown, we postulate that ubiquitin might be
involved in the modulatory mechanisms of immune response. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
It has been reported that ubiquitin-like proteins,
such as platelet activity suppressive lymphokine
(PASL), ubiquitin cross-reactive protein (UCRP) and
monoclonal non-speci¢c suppressor factor (MNSF),
were produced in characteristic cells, secreted to ex-
tracellular £uids, and exerted their immunoregula-
tory activities [1^3].
During parasitic infections, activated human
platelets produce oxygen metabolites, but PASL re-
leased from activated CD8 T-cells could inhibit
the oxygen metabolites production from activated
platelets. Thus, PASL containing human ubiquitin
moiety may be implicated in the mechanisms of
cell-to-cell signaling [1,4]. Moreover, it was demon-
strated that puri¢ed ubiquitin can inhibit platelet cy-
totoxicity [4]. UCRP, 15-kDa protein including ubiq-
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uitin-like moiety, is induced by IFNs in human lym-
phocytes and monocytes, and is released into extra-
cellular £uid from these cells, thereby involving in a
cell-to-cell signaling pathway [2,5^7]. In our labora-
tory, it was reported that ubiquitin-like moiety of
MNSF produced and released from murine T-cell
hybridoma by Con-A, was shown to have antigen-
non-speci¢c suppressive function on the immunore-
sponse [8], including suppression of immunoglobulin
secretion by LPS-induced murine splenocytes [3], IL-
4 secretion by bone marrow-derived mast cells [9],
and division in various tumor cell lines of murine
origin [10].
It has been well recognized that ubiquitin, a highly
conserved 8565-Da protein among the all eukaryotic
cells, is involved in the degradation of short-lived or
structurally abnormal intracellular proteins, and
plays important roles in ubiquitin^proteasome sys-
tem [11,12]. It was also reported that ubiquitin level
in plasma from healthy donors was less than 50 ng/
ml, although during parasitic infection, its level was
signi¢cantly elevated to 150^300 ng/ml [13]. Ubiqui-
tin was proved to stimulate di¡erentiation in T- and
B-cells derived from fractionated mouse spleen cells
through L-adrenergic receptors and adenylate cyclase
activation [14], and moreover ubiquitin added to the
splenocytes culture signi¢cantly inhibited IgG pro-
duction [5]. Therefore, not only ubiquitin-like pro-
teins, but also ubiquitin in the extracellular space
might have a possible regulatory role in the immu-
nological and/or in£ammatory processes, although
its functions remain obscure.
On the other hand, TNF-K is a pleiotropic cyto-
kine secreted by macrophage, mastocytes, T- and
B-lymphocytes, and natural killer cells in response
to various stimuli, such as LPS, viruses and parasites
[15]. Multiple studies have demonstrated the impor-
tant role of TNF-K in the pathogenesis of parasitic
infection [16,17]. In experimental leishmaniasis,
TNF-K is associated with progressive disease, and
also, in malaria infection, a high level of TNF-K
production has been correlated with severe compli-
cations [16].
The facts that ubiquitin, ubiquitin-like proteins
and TNF-K increase in extracellular £uid during par-
asitic infection, and that ubiquitin or ubiquitin-like
proteins also exert the immunoregulatory response in
vitro were previously described [2^5,16]. Therefore,
to explore the role of ubiquitin in the extracellular
space, we investigated the e¡ects of ubiquitin on
TNF-K production using macrophage-like cell line,
RAW 264.7. In this report, we demonstrated evi-
dence of the synergistic e¡ect of ubiquitin on LPS-
induced TNF-K production, mainly due to the acti-
vation at the transcriptional level.
2. Materials and methods
2.1. Cells and reagents
The mouse macrophage-like cell line RAW 264.7
was obtained from RCB cell bank, and maintained
in Dulbecco’s modi¢ed Eagle’s medium (DMEM)
supplemented with 10% heat-inactivated fetal bovine
serum at 37‡C in a humidi¢ed atmosphere of 5%
CO2 in air. LPS (Escherichia coli, 0127: B8 Westphal
type) was obtained from Difco and ubiquitin was
from Sigma (St. Louis, MO). Monoclonal hamster
anti-mouse TNF-K (K and L) IgG and polyclonal
rabbit anti-mouse TNF-K was from Genzyme (Cam-
bridge, MA). Peroxidase conjugated-IgG of goat
anti-rabbit IgG was from Caplet. All other reagents
were purchased from Miyata, Shimane, and were
used without further puri¢cation.
2.2. TNF-K assay
RAW 264.7 cells (1U105 cells/ml) were seeded into
96-well microplates, and 5 h later, they were stimu-
lated by the addition of LPS and/or ubiquitin. The
cells were incubated for an additional 14 h, and
supernatants were collected for TNF-K assay. Cul-
tured cells in each well were sonicated with 1.0 ml
of lysis bu¡er (25 mM HEPES, pH 7.5, 25 mM
L-mercaptoethanol, 10 WM pepstatin, 10 WM leupep-
tin, 1% (v/v) Triton X-100) after the standing on ice
bath for 30 min, and then cell lysates were assayed
for cellular TNF-K. The TNF-K concentrations were
determined by ELISA according to the method de-
scribed previously [18].
2.3. Total RNA preparation, cDNA synthesis, and
PCR ampli¢cation
Total RNA was prepared from cultured RAW
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264.7 cells by AGPC method [19]. Total RNA was
reverse-transcribed into cDNA by avian myelo-
blastosis virus-reverse transcriptase using random
9 mers as primers. PCR was carried out with Taq
DNA polymerase (Takara, Japan) in an automatic
DNA thermal cycler (Program Temp Control System
PC-700, Astec). For TNF-K (471 bp) and the con-
stitutive glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) cDNA (452 bp) ampli¢cation, the gene-
speci¢c primers were chosen as follows; 5P-CTCA-
GATCATCT-3P (sense) and 5P-TCACAGAGCA-
AT-3P (antisense), 5P-ACCACAGTCCATGCCAT-
CAC-3P (sense) and 5P-TCCACCACCCTGTTG-
CTGTA-3P (antisense), respectively. PCR was per-
formed for TNF-K and GAPDH under the following
conditions; denaturation at 94‡C for 1 min, and
94‡C for 35 s; annealing at 42‡C for 2 min, and
55‡C for 35 s; extension at 72‡C for 3 min, and
72‡C for 2 min; 40 and 35 cycles, respectively.
2.4. Northern blot analysis
Total RNA (10 Wg) was electrophoresed in 1.2%
agarose-formaldehyde gels and transferred overnight
to nylon ¢lters by capillary action in 20USSC. RNA
was cross-linked to the ¢lter by irradiation with UV
light. After prehybridization, the ¢lters were hybrid-
ized with random [K-32P]dCTP (3000 Ci per nmol)-
labeled probes for TNF-K. Then the ¢lters were
washed, dried and analyzed by autoradiography.
The blots were also hybridized with a GAPDH
cDNA probe, used as transfer control.
2.5. Determination of mRNA stability
RAW 264.7 cells were stimulated in the presence
of 1 Wg/ml LPS with or without 1 WM ubiquitin for
2 h, and then 5 Wg/ml actinomycin D was added to
culture medium. Total RNA was prepared and used
for Northern blot analysis as described above.
Densitometry of the gel photography was used to
determine and quantify the levels of TNF-K
mRNA. Estimates of the relative TNF-K mRNA
amounts were obtained by dividing the peak densi-
tometry area of TNF-K mRNA band by the area of
GAPDH band.
2.6. Assay for protein degradation
RAW 264.7 cells were stimulated in the presence
of 1 Wg/ml LPS with or without 1 WM ubiquitin for
14 h, and then 10 Wg/ml cycloheximide was added to
culture medium. At 30 and 60 min after addition of
cycloheximide, the cells were collected and sonicated
with 1.0 ml of lysis bu¡er after the standing on ice
bath and used for TNF-K assay.
3. Results
3.1. E¡ect of ubiquitin on LPS-induced TNF-K
production
RAW 264.7 cells (1U105 cells/ml) were cultured
with 10 ng/ml to 5 Wg/ml LPS to con¢rm the e¡ect
of LPS for TNF-K production. The maximum accu-
mulation of TNF-K in the culture medium was ob-
served at 14 h and 1 Wg/ml LPS concentration with
about 7.4-fold increase compared with that in the
absence of LPS (data not shown).
Fig. 1. Time course of LPS or LPS plus ubiquitin-induced
TNF-K production. RAW 264.7 cells (1U105 cells/ml) were cul-
tured with (a) or without (b) 1 WM ubiquitin in the presence
of 1 Wg/ml LPS. The ratio of the TNF-K production by 1 Wg/ml
LPS plus 1 WM ubiquitin to that by 1 Wg/ml LPS alone is
shown (U). The amounts of TNF-K in the culture supernatants
were determined by ELISA as described in the Section 2. Data
are the mean þ S.D. of six di¡erent experiments conducted in
triplicate. *P6 0.002, compared with LPS alone at 14 h.
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To see whether ubiquitin could a¡ect on the TNF-
K accumulation induced by LPS, RAW 264.7 cells
(1U105 cells/ml) were cultured with or without
1 WM ubiquitin in the presence of 1 Wg/ml LPS for
0^24 h. One WM ubiquitin and 1 Wg/ml LPS added to
RAW 264.7 cell cultures increased TNF-K produc-
tion by about 2-fold compared with LPS alone at
14 h (Fig. 1). Although maximum accumulation
was achieved at 14 h after addition of 1 WM ubiqui-
tin in the presence of 1 Wg/ml LPS, TNF-K accumu-
lation gradually declined with further incubation. As
included in Fig. 1, the ratio of ubiquitin plus LPS-
stimulated TNF-K accumulation to LPS-induced one
was almost constant at the level of about 2-fold ele-
vation. During the incubation of RAW 264.7 cells
with ubiquitin in the presence of LPS, the number
of RAW 264.7 cells was almost constant, therefore
this elevation of TNF-K was not dependent on cell
proliferation.
Next, we tested the e¡ect of ubiquitin concentra-
tion on LPS-induced TNF-K production. As shown
in Fig. 2, ubiquitin increased TNF-K production in
dose-dependent manner in the presence of LPS.
Maximal accumulation with about 2-fold elevation
was observed at the concentration of 1 WM ubiquitin
compared with 1 Wg/ml LPS alone. The addition of
10 WM ubiquitin to RAW 264.7 cell cultures de-
creased TNF-K production compared with 1 WM
ubiquitin. When ubiquitin (0.1, 1 and 10 WM, respec-
tively) alone was added to RAW 264.7 cells culture,
no signi¢cant increase of TNF-K was detected (Fig.
2).
To eliminate the possibility that some cytokines,
such as IFN-Q, contaminated during the ubiquitin
preparation, might confuse the e¡ect of ubiquitin
since ubiquitin used in these experiments was puri¢ed
from bovine red cells, we treated the ubiquitin prep-
aration at 100‡C, for 5 min. Ubiquitin is stable on
heat-treatment at 100‡C for 5 min [1], but not cyto-
kines [20^23]. One WM heat-treated ubiquitin caused
appreciable LPS-induced TNF-K accumulation; the
magnitude of increase by heat-treated ubiquitin was
comparable to that of non-heat-treated ubiquitin
(9.02 þ 0.61 ng/ml by 1 WM heat-treated ubiquitin
Fig. 2. E¡ect of increasing concentration of ubiquitin on LPS-
induced TNF-K production. RAW 264.7 cells (1U105 cells/ml)
were cultured with the indicated doses of ubiquitin (0.1, 1 and
10 WM, respectively) for 14 h in the presence (a) or absence
(b) of 1 Wg/ml LPS. The amounts of TNF-K in the culture
supernatants were determined by ELISA as described in the
Section 2. Data are the mean þ S.D. of six independent experi-
ments conducted in triplicate. *P6 0.002, at the concentration
of 1 WM ubiquitin compared with LPS alone.
Fig. 3. E¡ect of the time point of ubiquitin addition on LPS-in-
duced TNF-K production. RAW 264.7 cells (1U105 cells/ml)
were stimulated with 1 Wg/ml LPS for 14 h. Ubiquitin was
added at the 3.5 h before and 0, 3.5, 7 h after 1 Wg/ml LPS ad-
dition. The amounts of TNF-K in the culture supernatants were
determined by ELISA as described in the Section 2. The values
are the percentages mean þ S.D. of six di¡erent experiments
conducted in triplicate. Percent value was set as 100% when
TNF-K was induced by 1 Wg/ml LPS alone for 14 h (4.13 þ 0.47
ng/ml). *P6 0.01, at 33.5 h compared with 0 h. *P6 0.01, at
3.5 h compared with 0 h.
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and 8.85 þ 0.02 ng/ml by 1 WM non-heat-treated
ubiquitin, respectively). These observations ruled
out that ubiquitin-stimulated TNF-K accumulation
in the presence of LPS was caused by cytokines con-
taminated in the prepared ubiquitin. Hence, these
results suggest that ubiquitin itself acts as a synergis-
tic e¡ector for LPS on TNF-K production.
To investigate the time dependence for the syner-
gistic e¡ect of ubiquitin and LPS on TNF-K produc-
tion, RAW 264.7 cells (1U105 cells/ml) were stimu-
lated with LPS before or after treatment of ubiquitin.
As shown in Fig. 3, the pretreatment with ubiquitin
for 3.5 h before LPS treatment showed about 152%
of TNF-K accumulation compared with the addition
of LPS and ubiquitin simultaneously (approximately
200% at 0 h). The addition of ubiquitin at 3.5 h after
the treatment of RAW 264.7 cells with LPS showed
about 147% of TNF-K accumulation, and when
ubiquitin was added at 7 h after LPS-treatment, no
signi¢cant stimulation was observed. These results
suggest that the stimulatory e¡ect of ubiquitin on
the LPS-induced TNF-K production required the
presence of ubiquitin at the early period of the
TNF-K production.
3.2. E¡ect of ubiquitin on TNF-K secretion
TNF-K is composed of membrane-bound precur-
sor and mature secretable form [24^30]. To investi-
gate which form was increased by ubiquitin and
whether ubiquitin accelerates the release of LPS-in-
duced TNF-K to extracellular culture medium, both
cellular and extracellular TNF-K concentrations were
measured. Following 14 h incubation with or with-
out 1 WM ubiquitin in the presence of 1 Wg/ml LPS,
TNF-K in the culture medium and cell lysates were
measured, and determined as the extracellular and
cellular TNF-K, respectively. As shown in Table 1,
the accumulation of extracellular TNF-K exhibited
about two-fold elevation by the addition of 1 WM
ubiquitin in the presence of LPS (see Fig. 1). How-
ever, no elevation of the cellular TNF-K amounts
was observed (compared with that of LPS alone).
These observations suggest that the extracellular
TNF-K accumulation is major action of ubiquitin,
but not cellular accumulation.
3.3. E¡ect of ubiquitin on TNF-K mRNA synthesis
and degradation
Next, we considered whether ubiquitin treatment
with LPS could a¡ect the transcriptional level of
TNF-K production. To approach this issue, we inves-
Fig. 4. E¡ect of ubiquitin, LPS and both on TNF-K mRNA ex-
pression. RAW 264.7 cells (1U105 cells/ml) were stimulated
without (lane 1) or with 1 Wg/ml LPS (lane 2), 1 WM ubiquitin
(lane 3), and with 0.1 WM (lane 4), 1.0 WM (lane 5), or 10 WM
ubiquitin (lane 6) plus 1 Wg/ml LPS for 2 h. Cells were then an-
alyzed for the TNF-K mRNA expression by Northern blot
analysis. Total RNA (10 Wg) was hybridized either to radiola-
beled TNF-K cDNA probe or to radiolabeled GAPDH cDNA
probe and exposed to X-ray ¢lm for 18 h. The data are repre-
sentative of four independent experiments.
Table 1
Cellular and extracellular TNF-K concentrations after LPS or
LPS plus ubiquitin treatment
Substances added to culture TNF-K (ng/ml)
Cellular Extracellular
None 0.68 þ 0.20 0.65 þ 0.18
LPS (1 Wg/ml) 0.91 þ 0.23 4.80 þ 0.83
LPS (1 Wg/ml)+ubiquitin (1 WM) 0.89 þ 0.11 8.82 þ 0.03a
RAW 264.7 cells (1U105 cells/ml) were cultured with or with-
out 1 WM ubiquitin in the presence of 1 Wg/ml LPS for 14 h.
The amounts of TNF-K in the culture supernatants and cell ly-
sates are indicated as extracellular and cellular TNF-K, respec-
tively. The TNF-K concentrations were determined by ELISA is
as described in the Section 2. The values are the mean þ S.E. of
six experiments conducted in triplicate.
aP6 0.006, compared with extracellular TNF-K stimulated by
LPS alone.
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tigated the e¡ect of ubiquitin on TNF-K mRNA pro-
duction in RAW 264.7 cells. When 1U105 cells were
cultured with 1 Wg/ml LPS for 2 h, the increase of
TNF-K mRNA production was observed (Fig. 4,
lane 2), although the addition of 1 WM ubiquitin
alone did not enhance TNF-K mRNA expression
(lane 3). The coexistence of 1 WM ubiquitin with
1 Wg/ml LPS exhibited apparent augmentation
(two-fold) compared with 1 Wg/ml LPS alone (lanes
5 and 2). The treatment of 0.1 or 10 WM ubiquitin
plus 1 Wg/ml LPS slightly increased TNF-K mRNA
production compared with that of 1 Wg/ml LPS alone
(lanes 4, 6 and 2). It is worth noting that these results
present unambiguous evidence supporting the dose-
dependency of ubiquitin-induced TNF-K production
observed in Fig. 2.
Next, we performed TNF-K mRNA stability ex-
periments to assess whether ubiquitin would a¡ect
the half-life of TNF-K mRNA. After RAW 264.7
cells were cultured in the presence of 1 Wg/ml LPS
with or without 1 WM ubiquitin for 2 h, subsequently
5 Wg/ml actinomycin D was added into the culture
medium. The cells were cultured additional 1, 2 and
4 h, and the TNF-K mRNA levels were determined.
As shown in Fig. 5, the half-life of TNF-K mRNA
stimulated with LPS alone and that with ubiquitin in
the presence of LPS were determined to be approx-
imately 2.0 and 2.1 h, respectively. These results sug-
gest that the e¡ect of ubiquitin on the up-regulation
of TNF-K mRNA was dependent on the transcrip-
tion rate and scarcely on mRNA stability.
3.4. E¡ect of ubiquitin on TNF-K degradation
The possibility that ubiquitin treatment may cause
TNF-K accumulation by the suppression of TNF-K
degradation remains to be ruled out. To see TNF-K
degradation, RAW 264.7 cells were treated for 14 h
with or without 1 WM ubiquitin in the presence of
1 Wg/ml LPS, and then 10 Wg/ml cycloheximide was
added to the culture medium. The cells were col-
lected and sonicated with the lysis bu¡er at 30 and
60 min, and each lysate was then assayed for TNF-K
[18]. The TNF-K concentration in the cells stimulated
with or without ubiquitin in the presence of LPS
both proportionally decreased (Table 2). No obvious
di¡erence on TNF-K degradation between the cells
stimulated by LPS and LPS plus ubiquitin was de-
tected. These results indicate that ubiquitin treatment
never a¡ects the TNF-K degradation in the RAW
264.7 cells.
Fig. 5. E¡ect of ubiquitin on TNF-K mRNA stability. RAW
264.7 cells (1U105 cells/ml) were stimulated with 1 Wg/ml LPS
alone (a) or 1 Wg/ml LPS plus 1 WM ubiquitin (E) for 2 h.
After addition of 5 Wg/ml actinomycin D, total RNA was pre-
pared at the indicated time points. Cells were then analyzed for
the TNF-K mRNA expression by Northern blotting. Total
RNA (10 Wg) was hybridized either to radiolabeled TNF-K
cDNA probe or to radiolabeled GAPDH cDNA probe and ex-
posed to X-ray ¢lm for 18 h. TNF-K mRNA obtained before
the addition of actinomycin D by LPS alone was set as 100%.
The data are representative of four independent experiments.
Table 2
E¡ect of ubiquitin on TNF-K degradation
Substances added to culture Incubation time (min)
0 30 60
LPS (1 Wg/ml) 0.99 þ 0.03 0.86 þ 0.06 0.71 þ 0.03
LPS (1 Wg/ml)+ubiquitin (1 WM) 1.01 þ 0.05 0.81 þ 0.08 0.66 þ 0.02
RAW 264.7 cells (1U105 cells/ml) were cultured with or without 1 WM ubiquitin in the presence of 1 Wg/ml LPS for 14 h. After 10 Wg/
ml cycloheximide was added to culture medium, the cells were sonicated with the lysis bu¡er at the indicated time, and each lysate
was used for the TNF-K assay. The data are the mean þ S.D. of six experiments conducted in triplicate.
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4. Discussion
Ubiquitin, a highly conserved protein composed of
76 amino acids, is present in all eukaryotic cells, and
involved in the degradation of short-lived or struc-
turally abnormal proteins [31^34]. Though an extra-
cellular localization of ubiquitin was described in
human seminal £uid or in plasma where the ubiq-
uitin levels is less than 50 ng/ml, its function in this
£uid remains unclear [13]. The production of cyto-
toxic metabolites, which is produced by IgE antibod-
ies-activated platelets and exhibit killing properties
against larvae of Schistosoma mansoni [1,35^37] is
remarkably inhibited by PASL, released from Con-
A or antigen-stimulated CD8 T-cells. It was identi-
¢ed that its encoded nucleic acid and predicted ami-
no acid sequences were partially identical to human
ubiquitin, moreover puri¢ed ubiquitin was able to
inhibit platelet cytotoxicity [4]. Thus, ubiquitin itself
may possess unrecognized immunoregulatory activ-
ities in addition to its role in a variety of cellular
processes. TNF-K and PASL concentrations would
increase in patients with parasitic disease, such as
shistosomiasis, Hymenoptera venom hypersensitivity
(HVH), bacterial infection and neoplastic disease
[1,4,38]. Therefore, we began to interest ourselves
in the research whether ubiquitin had some in£uence
on TNF-K production.
In RAW 264.7 cell cultures, we observed that the
addition of 1 WM ubiquitin to 1 Wg/ml LPS resulted
in about two-fold increase in TNF-K production
compared with 1 Wg/ml LPS alone, however ubiqui-
tin alone did not a¡ect on TNF-K production. There-
fore, we aimed at determining the mechanism by
which ubiquitin augmented TNF-K production in
LPS-induced RAW 264.7 cells. When 1 WM ubiquitin
and 1 Wg/ml LPS were simultaneously added to
RAW 264.7 cells culture, maximal production of
TNF-K was observed. These results clearly demon-
strate the synergistic e¡ect of ubiquitin on LPS in-
duced TNF-K production in RAW 264.7 cells. We
found that 1 WM ubiquitin with LPS increased the
TNF-K mRNA levels about two-fold compared with
LPS alone. These data are almost paralleled with the
data obtained in Fig. 2, that TNF-K production was
increased about two-fold by the addition of 1 WM
ubiquitin in the presence of LPS compared with
LPS alone. Ubiquitin did not in£uence on the half-
life of LPS-induced TNF-K mRNA, and also on the
degradation of TNF-K. The e¡ect of ubiquitin on the
translational level was not undertaken, although the
increase in the both TNF-K mRNA and protein lev-
els by the ubiquitin with LPS was almost two-fold,
probably suggesting few implication of ubiquitin on
the translational level of TNF-K. Extracellular accu-
mulations of TNF-K by LPS plus ubiquitin were
twice than those by LPS alone, but cellular accumu-
lations of TNF-K were no di¡erence. These data in-
dicate that TNF-K induced by ubiquitin and LPS
would be immediately released into the extracellular
space, and never remain as the pro TNF-K molecule.
Many studies showed that processing of 26-kDa pro
TNF-K to mature 17-kDa TNF-K was blocked by
inhibitors of metalloproteinases, and pro TNF-K
was processed to mature TNF-K by several matrix
metalloproteinases, such as matrilysin and collage-
nase [39^41]. Recently, the processing protease of
TNF-K, called TNF-K-converting enzyme (TACE),
was puri¢ed and cloned [42]. We did not research
whether ubiquitin promoted TNF-K processing or
not, although the processing enzyme might possess
enough activities to cleave the pro TNF-K, even if
the pro TNF-K would increase twice by the treat-
ment of ubiquitin with LPS. It is widely accepted
that the expressions of the TNF-K gene by LPS are
regulated both at the transcriptional and post-tran-
scriptional levels [15]. Thus, we concluded that the
synergistic e¡ect of ubiquitin with LPS on TNF-K
accumulation was mainly caused by the up-regula-
tion of TNF-K gene transcription. This is the ¢rst
evidence as far as we know.
Recently, we observed that treatment with ubiqui-
tin alone did not augment the activity of the induci-
ble nitric oxide synthase (i-NOS), and stimulation of
RAW 264.7 cells with LPS plus ubiquitin also did
not a¡ect on the i-NOS production compared with
LPS alone (T. Nabika and I. Momose, unpublished
data). LPS binds to its own receptor and induces i-
NOS expression as well as TNF-K expression via the
activation of NF-UB [15,43]. Since ubiquitin in£u-
enced on the TNF-K production in RAW 264.7 cells
stimulated by LPS, but not on the i-NOS produc-
tion, ubiquitin may interact with transcriptional fac-
tor(s) other than NF-UB. Cytokines produced by ac-
tivated macrophages, such as interleukin-1 (IL-1),
IL-6 and IL-8, also have important e¡ects on immu-
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nological and in£ammatory responses [43^45]; there-
fore, it would be interesting to examine the e¡ect of
ubiquitin on these cytokines to clarify the speci¢city
for the action or the signal transduction pathways of
ubiquitin.
Liovera et al. [46] reported that injections of poly-
clonal goat anti-murine TNF IgG preparation into
tumor-bearing rats abolished the increase in muscle
ubiquitin gene expression, showing that TNF could
have an important role in the activation of the ubiq-
uitin-dependent proteolytic system during tumor
growth. This experiment was conducted in isolated
rat soleus muscles and human recombinant TNF-K
resulted in a remarkable increase in ubiquitin gene
expression [47]. Taken together with our own data, it
can be speculated that ubiquitin and TNF-K may
interact with each other in a multiple network in
vivo. Moreover, it remains unknown whether ubiq-
uitin acts on RAW 264.7 macrophage via its own
receptor or another mode, but Pancre¤ et al. [4] de-
scribed that PASL probably acted via a receptor
present on the platelet membrane. Therefore, several
studies in regard to the above described network or
action mechanisms of ubiquitin are currently under-
way to con¢rm the precise function of ubiquitin in
macrophage activation.
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